Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1401-1410 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|October 27, 2006
Multiple pathways contribute to the hyperproliferative responses from truncated granulocyte colony-stimulating factor receptorsJ Gits, D van Leeuwen, H P Carroll, et al.
Leukemia|November 4, 2006
Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad linkA A Zada, J A Pulikkan, D Bararia, et al.
Leukemia|April 1, 1991
Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factorsS Merchav, G Wagemaker, L M Souza, et al.
Leukemia|September 23, 2006
Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell deathE J Houwerzijl, N R Blom, J J L van der Want, et al.
Leukemia|September 23, 2006
Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemiaJ Pedersen-Bjergaard, D H Christiansen, F Desta, et al.
Leukemia|December 1, 2006
Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphomaT Haritunians, A Mori, J O'Kelly, et al.
Leukemia|December 8, 2006
Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cellsD Iglesias-Serret, M de Frias, A F Santidrián, et al.
Leukemia|December 8, 2006
Chromatin modifications and DNA double-strand breaks: the current state of playT C Karagiannis, A El-Osta
Leukemia|May 25, 2005
STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosisU Holtick, M Vockerodt, D Pinkert, et al.
Leukemia|May 28, 2005
Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cellsA Takeshita, K Shinjo, K Naito, et al.
Pageof 963

Showing results (1401-1410 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|October 27, 2006
Multiple pathways contribute to the hyperproliferative responses from truncated granulocyte colony-stimulating factor receptorsJ Gits, D van Leeuwen, H P Carroll, et al.
Leukemia|November 4, 2006
Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad linkA A Zada, J A Pulikkan, D Bararia, et al.
Leukemia|April 1, 1991
Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factorsS Merchav, G Wagemaker, L M Souza, et al.
Leukemia|September 23, 2006
Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell deathE J Houwerzijl, N R Blom, J J L van der Want, et al.
Leukemia|September 23, 2006
Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemiaJ Pedersen-Bjergaard, D H Christiansen, F Desta, et al.
Leukemia|December 1, 2006
Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphomaT Haritunians, A Mori, J O'Kelly, et al.
Leukemia|December 8, 2006
Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cellsD Iglesias-Serret, M de Frias, A F Santidrián, et al.
Leukemia|December 8, 2006
Chromatin modifications and DNA double-strand breaks: the current state of playT C Karagiannis, A El-Osta
Leukemia|May 25, 2005
STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosisU Holtick, M Vockerodt, D Pinkert, et al.
Leukemia|May 28, 2005
Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cellsA Takeshita, K Shinjo, K Naito, et al.
Pageof 963